文献速递瓣膜外科

外科主动脉瓣置换术后早期起搏器植入与远期死亡率

Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2017-04-19

该研究回顾Mayo Clinic 21年间5,842例无既往起搏器植入的外科主动脉瓣置换患者,早期(术后30天内)起搏器植入146例(2.5%)。多变量调整后,早期起搏器植入与死亡风险增加独立相关(HR 1.49;95%CI 1.20–1.84;P<0.001),提示瓣膜置换相关起搏器植入率应成为新瓣膜置换策略的重要考量。

要点

  • 术后30天内起搏器植入发生率为2.5%(146/5,842)。
  • 早期起搏器植入与远期死亡风险增加独立相关(HR 1.49)。
  • 瓣膜置换相关起搏器植入率应纳入新瓣膜策略考量。

核心结论

  • 外科主动脉瓣置换术后早期起搏器植入与远期死亡风险增加独立相关(HR 1.49;95%CI 1.20–1.84;P<0.001)。

研究设计与样本

  • 回顾性队列研究,纳入1993年1月至2014年6月Mayo Clinic 5,842例无既往起搏器植入的外科主动脉瓣置换患者,中位年龄73岁(范围65–79岁),中位射血分数62%(范围53%–68%),男性3,853例(66%),合并冠状动脉旁路移植2,553例(44%)。

主要发现

  • 早期起搏器植入146例(2.5%),发生于术后30天内。
  • 中位随访11.1年(范围5.8–16.5年),全因死亡率术后30天2.4%、1年6.4%、5年23.1%、10年48.3%、15年67.9%。
  • 多变量调整基线特征后,早期起搏器植入与死亡风险增加相关(HR 1.49;95%CI 1.20–1.84;P<0.001)。

临床怎么用

  • 外科主动脉瓣置换术后应关注早期起搏器植入这一并发症,并将其发生率纳入瓣膜置换策略选择与患者沟通的考量。

局限性

  • 本研究为单中心回顾性分析,结论可能受未测量混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The need for pacemaker implantation is a well-described complication of aortic valve replacement. Not so well described is the effect such an event has on long-term outcome. This study reviewed a 21-year experience at the Mayo Clinic (Rochester, Minnesota) with aortic valve replacement to understand the influence of early postoperative pacemaker implantation on long-term mortality rates more clearly. METHODS: This study retrospectively reviewed the records of 5,842 patients without previous pacemaker implantation who underwent surgical aortic valve replacement from January 1993 through June 2014. The median age of these patients was 73 years (range, 65 to 79 years), the median ejection fraction was 62% (range, 53% to 68%), 3,853 patients were male (66%), and coronary artery bypass graft operation was performed in 2,553 (44%) of the patients studied. Early pacemaker implantation occurred in 146 patients (2.5%) within 30 days of surgical aortic valve replacement. RESULTS: The median follow-up of patients was 11.1 years (range, 5.8 to 16.5 years), and all-cause mortality rates were 2.4% at 30 days, 6.4% at 1 year, 23.1% at 5 years, 48.3% at 10 years, and 67.9% at 15 years postoperatively. Early pacemaker implantation was associated with an increased risk of death after multivariable adjustment for baseline patients' characteristics (hazard ratio, 1.49; 95% confidence interval, 1.20, 1.84; p < 0.001). CONCLUSIONS: Early pacemaker implantation as a complication of surgical aortic valve replacement is associated with an increased risk of long-term death. Valve replacement-related pacemaker implantation rates should be important considerations with respect to new valve replacement paradigms, especially in younger and lower-risk patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Greason KL, Lahr BD, Stulak JM, et al. Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement. Ann Thorac Surg. 2017. PMID: 28433222. doi:10.1016/j.athoracsur.2017.01.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。